Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.5760
+0.0080 (1.41%)
Jun 11, 2026, 5:24 PM CET
Nanologica AB Market Cap
Nanologica AB has a market cap or net worth of 189.37 million as of June 11, 2026. Its market cap has increased by 76.40% in one year.
Market Cap
189.37M
Enterprise Value
269.19M
Revenue
31.83M
Ranking
n/a
PE Ratio
2.22
Stock Price
0.58
Market Cap Chart
Since October 30, 2015, Nanologica AB's market cap has increased from 73.54M to 189.37M, an increase of 157.50%. That is a compound annual growth rate of 9.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 186.74M | 170.92% |
| Dec 30, 2025 | 68.93M | -57.14% |
| Dec 30, 2024 | 160.81M | -57.22% |
| Dec 29, 2023 | 375.92M | 33.47% |
| Dec 30, 2022 | 281.66M | -27.01% |
| Dec 30, 2021 | 385.87M | 3.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 228.19M |
| Xbrane Biopharma AB | 212.24M |
| Initiator Pharma | 184.82M |
| Xintela AB | 172.25M |
| Elicera Therapeutics AB | 169.51M |
| Active Biotech AB | 167.92M |
| Diamyd Medical AB | 167.69M |
| AlzeCure Pharma AB | 159.16M |